Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, Texas.
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
Am J Physiol Renal Physiol. 2020 Mar 1;318(3):F772-F792. doi: 10.1152/ajprenal.00504.2019. Epub 2020 Jan 27.
Klotho- and beclin 1-driven autophagy extends life. We examined the role of beclin 1 in modifying acute kidney injury (AKI) and whether beclin 1 mediates Klotho's known renoprotective action in AKI. AKI was induced by ischemia-reperfusion injury in mice with different levels of autophagy activity by genetic manipulation: wild-type (WT) mice with normal beclin 1 expression and function, mice with normal beclin 1 levels but high activity through knockin of gain-of-function mutant beclin 1 (), mice with low beclin 1 levels and activity caused by heterozygous global deletion of beclin 1 (), or mice with extremely low beclin 1 activity from knockin of the mutant constitutively active beclin 1 inhibitor Bcl-2 (). Klotho was increased by transgenic overexpression () or recombinant Klotho protein administration. After ischemia-reperfusion injury, mice (high autophagy) had milder AKI and and mice (low autophagy) had more severe AKI than WT mice. mice had milder AKI, but its renoprotection was partially attenuated in mice and was significantly reduced, although not completely abolished, in mice. Recombinant Klotho protein conferred more renoprotection from AKI in WT mice than in or mice. Klotho reduced beclin 1/Bcl-2 protein complexes and increased autophagy activity, but this effect was less prominent in mice or cells with . Transfected Bcl2 or Becn1 decreased or increased autophagy activity and rendered cells more susceptible or more resistant to oxidative cytotoxicity, respectively. In conclusion, beclin 1 confers renoprotection by activating autophagy. Klotho protects the kidney partially via disruption of beclin 1/Bcl-2 interactions and enhancement of autophagy activity.
Klotho 和 beclin 1 驱动的自噬延长寿命。我们研究了 beclin 1 在修饰急性肾损伤 (AKI) 中的作用,以及 beclin 1 是否介导 Klotho 在 AKI 中的已知肾保护作用。通过遗传操作在不同自噬活性水平的小鼠中诱导 AKI:具有正常 beclin 1 表达和功能的野生型 (WT) 小鼠、通过敲入获得功能突变 beclin 1 () 的具有正常 beclin 1 水平但高活性的小鼠、具有低 beclin 1 水平和活性的杂合子全局缺失 beclin 1 () 的小鼠,或由于突变组成型激活 beclin 1 抑制剂 Bcl-2 的 knockin 而具有极低 beclin 1 活性的小鼠 ()。Klotho 通过转基因过表达 () 或重组 Klotho 蛋白给药增加。缺血再灌注损伤后,高自噬的 小鼠 () 发生更轻微的 AKI,而低自噬的 和 小鼠 () 发生更严重的 AKI。 小鼠发生更轻微的 AKI,但在 小鼠中其肾保护作用部分减弱,而在 小鼠中虽未完全消除但明显降低。重组 Klotho 蛋白在 WT 小鼠中比在 或 小鼠中提供了更多的 AKI 肾保护作用。Klotho 减少了 beclin 1/Bcl-2 蛋白复合物并增加了自噬活性,但在 小鼠或细胞中,这种作用不那么明显。转染的 Bcl2 或 Becn1 减少或增加了自噬活性,并分别使细胞对氧化细胞毒性更敏感或更耐受。总之,beclin 1 通过激活自噬来提供肾保护。Klotho 通过破坏 beclin 1/Bcl-2 相互作用和增强自噬活性来部分保护肾脏。